Marie President, MD
She | Her | HersInternal MedicineMarie President, MD
She | Her | HersInternal MedicineOn this page
About me
Dr. Marie President is an internal medicine specialist who provides comprehensive primary care for adults. When caring for patients, she emphasizes prevention, chronic disease management and building long-term partnerships with patients to support their physical and emotional well-being.
In her research, President focuses on developing innovative models of care, improving treatment outcomes and advancing patient access through primary care leadership and digital health initiatives.
President earned her medical degree from David Geffen School of Medicine at UCLA. She completed a residency in internal medicine at Stanford University Medical Center.
When not caring for patients, President enjoys leadership development, mentoring physicians, community engagement and spending time outdoors. She serves on nonprofit and hospital boards and she is passionate about creating healthier communities and expanding equitable access to care.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, Stanford University Medical Center-GME
Degree
- MD, UCLA David Geffen School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%226803%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%226803%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.